Global Influenza Vaccine Market: Industry Analysis & Outlook

Transcription

1 Industry Research by Koncept Analytics Global Influenza Vaccine Market: Industry Analysis & Outlook January

2 Executive Summary Influenza, also known as flu, is a contagious disease which spreads from person to person very rapidly. When an infected person sneezes or coughs the virus spreads to those close by, affecting immuno-compromised patients the most. The influenza virus is broadly classified as influenza A, influenza B, and influenza C. The influenza vaccine come in both inactive and weakened viral forms. The global influenza vaccine market is relatively untouched and has huge potential to treat any major outbreak. The influenza vaccine market in the US is the largest market globally because of its strong dynamics and a great scope of innovation in the region. The growth factors of the market include increase in incidence of H1N1 outbreaks, rising spending on public healthcare programs, growth of the market in emerging economies, escalating ageing population and increase in spending on medicines and healthcare expenditure. The global influenza vaccine market is trending with development of new drugs, use of new technologies, rise in FDA approvals, increase in efficiency rate of influenza vaccines, booming public private partnership and growing awareness. However, the market growth will be hindered by complex development and production process, unclear process for introduction of new vaccines and high R&D costs. The report offers an in-depth analysis of the global influenza vaccine market along with regional insights. The top notch players in the market exhibit a very close competition. The report profiles Sanofi S.A, Novartis AG, AstraZeneca PLC and GlaxoSmithKline Plc. 2

3 Billion Doses US$ Billion Increased awareness about influenza outbreaks and rising government support has helped the growth of the influenza vaccine market at large. Global Influenza Vaccine Market Forecast by Value The global influenza vaccine market is anticipated to reach US$.. billion by 2021, increasing from US$.. billion in 2017, growing at a CAGR of.. % for the period spanning Global pandemic influenza vaccine production capacity held..% of the total production capacity in Global pandemic influenza vaccines production capacity is projected to grow at a CAGR of..% for the period spanning The production capacity is estimated to reach.. billion doses by the end of 2021, increasing from..billion doses in Global Influenza Vaccine Production Capacity by Indication (2016) Global Pandemic Influenza Vaccine Production Capacity Forecast Seasonal Influenza Pandemic Influenza

4 US$ Billion Billion Doses With increased use of new technologies, the influenza vaccine market is heading towards greater opportunities of providing fast and reliable vaccinations to treat influenza. Global Seasonal Influenza Vaccine Production Capacity Forecast Global seasonal influenza vaccine production capacity is expected to reach..billion doses by 2021, increasing from..billion doses in The production capacity is expected to grow at a CAGR of..% for the period spanning XX was the largest market for influenza vaccines, capturing..% of the total market share in terms of value Global Influenza Vaccine Market by Region (2016) The US influenza vaccine market is projected to grow at a CAGR of..% for the period spanning , reaching US$.. billion by The US Influenza Vaccine Market Forecast by Value The US Japan Germany The UK ROW

5 Contact Us: Disclaimer This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy. Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P T: M: vikas@konceptanalytics.com 5